Plataforma BIOBADASER III

Registro Español de Acontecimientos Adversos de Terapias Dirigidas en Enfermedades Reumáticas

Biobadaser Fase III

Impact of multimorbidity on the first ts/bDMARD effectiveness and retention rate after two years of follow-up in patients with rheumatoid arthritis from the BIOBADASER registry

19/03/2024

Calvo-Gutiérrez, J., López-Medina, C., Otero-Varela, L., Escudero-Contreras, A., Ortega-Castro, R., Ladehesa-Pineda, L., ... & Castrejón, I.

Arthritis Research & Therapy

https://doi.org/10.1186/s13075-024-03287-9

doi: 10.1186/s13075-024-03287-9